Primary Immunodeficiency Diseases (PID) are genetic immune system disorders causing increased infection susceptibility, morbidity, and shortened lifespans. This grant is for addressing the critical need for improved understanding and timely diagnosis of PID. Despite their diverse nature, prompt diagnosis and treatment significantly enhance life quality and longevity. Current challenges include the complexity of PID, limited genotype-phenotype understanding, and a general lack of awareness among healthcare providers and the public. This impedes early recognition and intervention. This initiative aims to bridge these gaps through enhanced public awareness campaigns and targeted provider education, ultimately facilitating prompt diagnosis via clinical suspicion and diagnostic testing for affected individuals.
Opportunity ID: 344796
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-CD-23-0057 |
| Funding Opportunity Title: | Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.135 — Centers for Research and Demonstration for Health Promotion and Disease Prevention |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 07, 2023 |
| Last Updated Date: | Apr 07, 2023 |
| Original Closing Date for Applications: | May 22, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Current Closing Date for Applications: | May 22, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
| Archive Date: | Jun 22, 2023 |
| Estimated Total Program Funding: | $15,000,000 |
| Award Ceiling: | $3,000,000 |
| Award Floor: | $1,000,000 |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities County governments Independent school districts City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Private institutions of higher education Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Centers for Disease Control – OD |
| Description: | Primary Immunodeficiency Diseases (PID) are a group of primarily single-gene disorders of the immune system. Primary denotes the genetic nature of the defects, differentiating them from secondary or acquired immunodeficiencies caused by malnutrition, infection, chemotherapy, or other external agents. The defining characteristics of primary immunodeficiency diseases make them candidates for a public health intervention approach. Although the clinical manifestations and underlying genetic defects are diverse, primary immunodeficiency diseases share the common feature of increased susceptibility to infection and collectively result in substantial morbidity and shortened life spans. However prompt diagnosis and treatment can be lifesaving and may result in marked improvements in the quality and length of life. The heterogeneity of primary immunodeficiency diseases and the limited understanding of the relation between genotype and phenotype also hinder intervention efforts. Additional obstacles include the difficulty of diagnosis in the absence of a high index of suspicion and the lack of awareness of health care providers and the public which impedes the timely recognition of affected person by using a combination of clinical suspicion and diagnostic testing. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Scott Bowen
msb4@cdc.gov Email:msb4@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 344796 Full Announcement-Full Announcement -> Foa_Content_of_CDC-RFA-CD-23-0057 (1).pdf
Packages
| Agency Contact Information: | Scott Bowen msb4@cdc.gov Email: msb4@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.135 | CDC-RFA-CD-23-0057 | Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease | PKG00281062 | Apr 07, 2023 | May 22, 2023 | View |
Package 1
Mandatory forms
344796 SF424_4_0-4.0.pdf
344796 Project_AbstractSummary_2_0-2.0.pdf
344796 SFLLL_2_0-2.0.pdf
344796 SF424A-1.0.pdf
344796 BudgetNarrativeAttachments_1_2-1.2.pdf
344796 ProjectNarrativeAttachments_1_2-1.2.pdf
Optional forms
344796 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
